FATE - Fate Therapeutics Inc. (FATE) CEO Scott Wolchko on Q2 2021 Results - Earnings Call Transcript
Fate Therapeutics, Inc. (FATE) Q2 2021 Earnings Conference Call August 04, 2021, 05:00 PM ET Company Participants Scott Wolchko - President and CEO Ed Dulac - CFO Conference Call Participants Yigal Nochomovitz - Citi Michael Schmidt - Guggenheim Alethia Young - Cantor Fitzgerald Michael Yee - Jefferies Daina Graybosch - SVB Leerink Ben Burnett - Stifel Peter Lawson - Barclays Matt Biegler - Oppenheimer Mara Goldstein - Mizuho Srikripa Devarakonda - Truist Securities Nick Abbott - Wells Fargo Presentation Operator Welcome to the Fate Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time all participants are in a listen-only mode. This call is being webcast live on the Investors section of Fate's website at fatetherapeutics.com. As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics. You may begin. Scott Wolchko Thank you. Good afternoon, and thanks
For further details see:
Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q2 2021 Results - Earnings Call Transcript